XL Axiata Tbk. vs Merck Tbk. — how do they compare? XL Axiata Tbk. trades at Rp2,530 (market cap 46.41T, 953K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 21.9K 24h volume). The key difference: XL Axiata Tbk. is far larger — about 27.3× Merck Tbk.'s market cap, and XL Axiata Tbk. is more actively traded (953K versus 21.9K). Which is the better fit depends on your goals.
| EXCL | MERK | |
|---|---|---|
Market Cap | 46.41T | 1.7T |
Volume | 953K | 21.9K |
Lot | 9.53K | 219 |
Turnover | 2.4B | 83.99M |
Average Price | 2,522.36 | 3,834.93 |
Value | 2.4B | 83.99M |
Indicative Equilibrium Price | 2,550 | 3,850 |
Indicative Equilibrium Volume | 45.3K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.
Read more on EXCL →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →